Deborah Money CM | |
---|---|
Academic background | |
Education | BSc, Microbiology MD, 1985, University of British Columbia |
Academic work | |
Institutions | University of British Columbia |
Deborah McColl Money CM is a Canadian obstetric and gynaecological infectious disease specialist. As a professor at the University of British Columbia,she was the first non-US President of the Infectious Diseases Society for Obstetrics and Gynecology from 2010 until 2012.
Money was born to Scottish-Canadian parents Irene and Tom,a Professor Emeritus in Chemistry at the University of British Columbia (UBC). [1] Growing up,she attended Crofton House School [2] where she earned a job working in Edith and Pat McGeer's laboratory on UBC's Point Grey campus helping with basic tasks. [3] Money earned her Bachelor of Science and medical degree from UBC,followed by her residency in Obstetrics and Gynecology. [4] As she completed her residency,Money joined the Infectious Diseases Society for Obstetrics and Gynecology and accepted a fellowship in reproductive infectious diseases at the University of Washington. [5]
Following her fellowship,Money returned to Canada and became the first individual in the country with this combined training. She subsequently joined the Oak Tree Clinic and worked with David Patrick to convince the provincial government to institute universal testing for all pregnant women. [6] She also began specializing in obstetric and gynecological infectious diseases at B.C. Women's Hospital &Health Centre. [7]
As a professor at UBC,Money became the first non-US President of the Infectious Diseases Society for Obstetrics and Gynecology from 2010 until 2012. [4] While serving in this role,she received funding from the Canadian Institutes of Health Research and Genome British Columbia to research how micro-organisms affect human health. Her project used genome sequencing tools to determine what contributes to a healthy balance of microorganisms in the vagina,and how an imbalance may be associated with preterm delivery,genital tract infection and overall reproductive health. [8] Upon stepping down as president,Money began leading the Vancouver portion of a national study on how pregnant women who have been vaccinated can pass on antibodies to their baby. [9] In recognition of her academic achievements,Money received the 2013 Woman of Distinction Award in the Technology,Science &Research category from the YWCA Metro Vancouver and was awarded the Queen Elizabeth II Diamond Jubilee Medal. [10]
In 2016,Money was appointed Executive Vice Dean of the Faculty of Medicine where she would "provide operational leadership to Department Heads and School Directors,as well as oversight of academic standards and the administrative functions of the Faculty." [11] While serving in this role,Money became the lead investigator for the HPV in HIV Study Group which studied the safety and potential efficacy of vaccination against the human papillomavirus (HPV) in HIV-positive women. [12] In recognition of her accomplishments,Money was the recipient of the Women's Health Research Institute's Career Contribution to Women's Health Research Award [13] and Lifetime Achievement Award from the Infectious Diseases Society of Obstetrics and Gynecology. [14]
In her final year as Executive Vice Dean of the Faculty of Medicine,Money was awarded a Red Ribbon Award from AIDS Vancouver in recognition of her "years of work and dedication to help support people living with HIV/AIDS." [15] During the COVID-19 pandemic in Canada,Money received $3.1 million in funding from the COVID-19 Immunity Task Force to research antenatal serum samples of pregnant women. The aim was to track trends in the level of SARS-CoV-2 infection amongst pregnant women in all provinces and territories of Canada. [16] She also announced her decision to not stand for reappointment of Executive Vice-Dean following her term ending June 30,2020. [17]
She was appointed as a Member of the Order of Canada in 2023. She currently resides in Vancouver. [18]
Bacterial vaginosis (BV) is an infection of the vagina caused by excessive growth of bacteria. Common symptoms include increased vaginal discharge that often smells like fish. The discharge is usually white or gray in color. Burning with urination may occur. Itching is uncommon. Occasionally,there may be no symptoms. Having BV approximately doubles the risk of infection by a number of sexually transmitted infections,including HIV/AIDS. It also increases the risk of early delivery among pregnant women.
The Papanicolaou test is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix or,more rarely,anus. Abnormal findings are often followed up by more sensitive diagnostic procedures and,if warranted,interventions that aim to prevent progression to cervical cancer. The test was independently invented in the 1920s by the Greek physician Georgios Papanikolaou and named after him. A simplified version of the test was introduced by the Canadian obstetrician Anna Marion Hilliard in 1957.
Cervical cancer is a cancer arising from the cervix or in the any layer of the wall of the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on,typically no symptoms are seen. Later symptoms may include abnormal vaginal bleeding,pelvic pain or pain during sexual intercourse. While bleeding after sex may not be serious,it may also indicate the presence of cervical cancer.
Trichomoniasis (trich) is an infectious disease caused by the parasite Trichomonas vaginalis. About 70% of affected people do not have symptoms when infected. When symptoms occur,they typically begin 5 to 28 days after exposure. Symptoms can include itching in the genital area,a bad smelling thin vaginal discharge,burning with urination,and pain with sex. Having trichomoniasis increases the risk of getting HIV/AIDS. It may also cause complications during pregnancy.
Human papillomavirus infection is caused by a DNA virus from the Papillomaviridae family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. In some cases,an HPV infection persists and results in either warts or precancerous lesions. These lesions,depending on the site affected,increase the risk of cancer of the cervix,vulva,vagina,penis,anus,mouth,tonsils,or throat. Nearly all cervical cancer is due to HPV,and two strains –HPV16 and HPV18 –account for 70% of all cases. HPV16 is responsible for almost 90% of HPV-positive oropharyngeal cancers. Between 60% and 90% of the other cancers listed above are also linked to HPV. HPV6 and HPV11 are common causes of genital warts and laryngeal papillomatosis.
Cervical intraepithelial neoplasia (CIN),also known as cervical dysplasia, is the abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer. More specifically,CIN refers to the potentially precancerous transformation of cells of the cervix.
The Women's Interagency HIV Study (WIHS) was established in August 1993 to investigate the impact and progression of HIV disease in women. The WIHS enrolls both HIV-positive and HIV-negative women. The core portion of the study includes a detailed and structured interview,physical and gynecologic examination,and laboratory testing. The WIHS participants are also asked to enroll in various sub-studies,such as cardiovascular,metabolic,musculoskeletal,and neurocognition. New proposals for WIHS sub-studies are submitted for approval by various scientific investigators from around the world.
A sexually transmitted infection (STI),also referred to as a sexually transmitted disease (STD) and the older term venereal disease (VD),is an infection that is spread by sexual activity,especially vaginal intercourse,anal sex,oral sex,or sometimes manual sex. STIs often do not initially cause symptoms,which results in a risk of passing the infection on to others. Symptoms and signs of STIs may include vaginal discharge,penile discharge,ulcers on or around the genitals,and pelvic pain. Some STIs can cause infertility.
HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations:pregnancy,childbirth,and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention,and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC):In the United States and Puerto Rico between the years of 2014–2017,where prenatal care is generally accessible,there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.
Janet L. Mitchell was an American physician known for her advances in perinatal HIV/AIDS treatment. During the early days of the AIDS epidemic in the U.S. Mitchell developed protocols for health treatment of pregnant women who were HIV positive or at risk for developing AIDS. She advocated against mandatory testing and testifying before Congress,she advocated in favor of an inclusive approach to health care and social services. One of her innovations derived from a study that saw a 70% decrease in HIV transmission to babies when AZT was administered to their mothers during the pregnancy.
B. Brett Finlay,is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections,as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity,and the role of the microbiota in infections,asthma,and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories,Microbiology and Immunology,and Biochemistry and Molecular Biology,and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt:Saving Your Child from an Oversanitized World and The Whole-Body Microbiome:How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
Jennifer Gunter is a Canadian-American gynecologist,a New York Times columnist covering women's health,an author,and a specialist in chronic pain medicine and vulvovaginal disorders.
Sharon Louise Hillier is an American microbiologist. She is the Richard Sweet Endowed Chair in Reproductive Infectious Disease and vice chair of the department of obstetrics,gynecology and reproductive sciences at the University of Pittsburgh Medical Center (UPMC) and Magee-Women's Research Institute.
Janice Jennifer Eng is a professor in the University of British Columbia's Department of Physical Therapy and Canada Research Chair in Neurological Rehabilitation.
Amina Zoubeidi is a Canadian research scientist and prostate cancer researcher. She's a scientist at the Vancouver Coastal Health Research Institute and an associate professor in the Department of Urologic Sciences at the University of British Columbia. During her tenure at UBC,Zoubeidi and her research team developed the first drug that targets and blocks BRN2,thus stopping Neuroendocrine prostate cancer (NEPC) tumours and creating a possible treatment for the previously thought incurable disease.
Gina Suzanne Ogilvie is a Canadian global and public health physician. She is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention,and Professor at the University of British Columbia in their School of Population and Public Health.
Mona R. Loutfy is a Canadian clinician-scientist and infectious disease specialist.
Geeta Krishna Swamy is an American OBGYN. She is a professor of obstetrics and gynecology at Duke University and Associate Vice President for Research and Vice Dean for Scientific Integrity.
Pamela Toliman is a medical researcher from Papua New Guinea (PNG) who has researched areas such as sexually transmitted diseases,HIV/AIDS,cervical cancer and COVID-19.
Lisa Cencia Rohan is an American chemist and pharmaceutical scientist.
Deborah Money publications indexed by Google Scholar